GLP-1(32–36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs

We have previously demonstrated in human subjects who under euglycemic clamp conditions GLP-1(9–36)amide infusions inhibit endogenous glucose production without substantial insulinotropic effects. An earlier report indicates that GLP-1(9–36)amide is cleaved to a nonapeptide, GLP-1(28–36)amide and a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Peptides
Hlavní autoři: Elahi, Dariush, Angeli, Franca S., Vakilipour, Amin, Carlson, Olga D., Tomas, Eva, Egan, Josephine M., Habener, Joel F., Shannon, Richard P.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5155305/
https://ncbi.nlm.nih.gov/pubmed/24937653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.peptides.2014.06.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky